ACOG Revenue second quarter 2027 Y/Y Growth Comment
Alpha Cognition Inc. achieved in the second quarter 2027, above Company average Revenue surge of 267.05% year on year, to $ 6.09 millions.
According to the results reported in the second quarter 2027, Alpha Cognition Inc. achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While Alpha Cognition Inc.' s Revenue doubling of 267.05% ranks overall at the positon no. 0 in the second quarter 2027.
Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027
Alpha Cognition's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
72.42 %
25.05 %
-43.4 %
(Jun 30 2026)
ACOG's II. Quarter Q/Q Revenue Comment
Alpha Cognition Inc. achieved in the II. Quarter 2027 above company average sequential Revenue jump of 72.61%, to $ 6.09 millions, from $3.53 millions in the first quarter. ACOG is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry Alpha Cognition Inc. achieved highest sequential Revenue growth. While Alpha Cognition's Revenue growth quarter on quarter, overall rank is 0.
Alpha Cognition Inc. achieved in the II. Quarter 2027 above company average sequential Revenue jump of 72.61%, to $ 6.09 millions, from $3.53 millions in the first quarter. ACOG is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Biotechnology & Pharmaceuticals industry Alpha Cognition Inc. achieved highest sequential Revenue growth. While Alpha Cognition's Revenue growth quarter on quarter, overall rank is 0.
Alpha Cognition's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 15.26
$ 10.83
$ 10.22
$ 0.00
$ 0.00
Y / Y Revenue Growth (TTM)
-
-
-
-
-
Year on Year Revenue Growth Overall
Ranking
#
#
#
#
#
Seqeuential Revenue Change (TTM)
40.97 %
5.92 %
-
-
-
Seq. Revenue Growth (TTM) Overall
Ranking
#
#
#
#
#
Cumulative Revenue growth Comment
Alpha Cognition saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 267.05% year on year, to $ 15 millions if the fiscal year would have ended in Jun 30 2026. Alpha Cognition's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Alpha Cognition realized the fastest Revenue growth, in Biotechnology & Pharmaceuticals industry. But from twelve months ended Mar 31 2026 rise was beneth at 40.97 % from $10.83 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 40.97 % increase from $10.83 millions in the period from Mar 31 2026 to Jun 30 2025.
Alpha Cognition Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
Alpha Cognition saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 267.05% year on year, to $ 15 millions if the fiscal year would have ended in Jun 30 2026. Alpha Cognition's trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Alpha Cognition realized the fastest Revenue growth, in Biotechnology & Pharmaceuticals industry. But from twelve months ended Mar 31 2026 rise was beneth at 40.97 % from $10.83 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 40.97 % increase from $10.83 millions in the period from Mar 31 2026 to Jun 30 2025.
Alpha Cognition Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About Alpha Cognition Revenue Growth Rates (ACOG), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
466.40%